NeOnc Technologies Holdings Inc (NTHI) Stock Analysis
Verdict: AVOID
Aggressive insider buying fights a liquidity crisis as NTHI burns through cash awaiting glioblastoma Phase 2a results.
Investment score: 38/100
Analysis as of
Is NeOnc Technologies Holdings Inc stock worth reviewing? The TradeMates thesis
Avoid due to extreme liquidity risk and failing technicals, despite bullish insider activity.
7-factor investment score
- Valuation: 25/100 (weight 20%)
- Financial Health: 10/100 (weight 15%)
- Technical Momentum: 30/100 (weight 15%)
- Earnings Quality: 20/100 (weight 15%)
- Insider Sentiment: 95/100 (weight 10%)
- Analyst Consensus: 85/100 (weight 10%)
- Risk-Adjusted Return: 35/100 (weight 15%)
NeOnc Technologies Holdings Inc opportunities and risks
What speaks for NTHI
- Intensifying Insider Conviction
What speaks against NTHI
- Immediate Solvency Crisis
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| NTHI | n/a | 0.0x | n/a | 0.0% | 0.0% | -24.0% |
| GRIN.CN | n/a | 2.7x | 35.0x | 43.8% | 0.9% | -0.1% |
| PLYX | n/a | 0.0x | n/a | 0.0% | 0.0% | -3.1% |
| AARD | n/a | 0.0x | n/a | 0.0% | 0.0% | -49.1% |
| CWEB.TO | n/a | 1.1x | n/a | 42.4% | -75.1% | -27.1% |
| RANI | n/a | 15.7x | n/a | 94.9% | -929.1% | -34.5% |
| Peer median | n/a | 1.1x | n/a | 42.4% | 0.0% | -27.1% |
Frequently asked questions about NeOnc Technologies Holdings Inc (NTHI)
Is NTHI stock a good investment?
The TradeMates model rates NeOnc Technologies Holdings Inc as AVOID with an investment score of 38/100. Avoid due to extreme liquidity risk and failing technicals, despite bullish insider activity. This is algorithmic model output, not personal investment advice.
Is NTHI stock a buy?
The TradeMates model verdict for NTHI is AVOID with an investment score of 38/100. Treat this as a model signal to review, not a personal buy recommendation.